Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liht Cannabis Corp, formerly known as Marapharm Ventures Inc., was a publicly traded cannabis company focused on the cultivation, production, and distribution of medical and recreational marijuana. The company operated significant facilities in North America, including major cultivation sites in Nevada and Washington state. In 2019, the company rebranded as Organic Flower Investments Group Inc. to pivot toward a broader investment strategy within the cannabis sector. Shortly thereafter, its key assets and intellectual property were acquired by The Green Organic Dutchman (TGOD) in a deal valued at approximately $290 million CAD. The acquisition integrated Liht's production capacity and organic growing methodologies into TGOD's global operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liht Cannabis Corp.